Andreas Klein

1.2k total citations
39 papers, 932 citations indexed

About

Andreas Klein is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Andreas Klein has authored 39 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Andreas Klein's work include Hepatitis B Virus Studies (6 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related Molecular Pathways (5 papers). Andreas Klein is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related Molecular Pathways (5 papers). Andreas Klein collaborates with scholars based in Germany, United States and Israel. Andreas Klein's co-authors include Oded Meyuhas, Cara Reiter–Brennan, A. Graessmann, M. Graessmann, Daniel Shouval, Eithan Galun, Folke Schriever, Oliver Miera, Norbert Arnold and Sven Golfier and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Endocrinology.

In The Last Decade

Andreas Klein

39 papers receiving 915 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Klein Germany 20 445 222 163 160 131 39 932
Stefanie Mandl United States 14 789 1.8× 442 2.0× 118 0.7× 323 2.0× 234 1.8× 25 1.4k
Francesca De Nicola Italy 18 666 1.5× 236 1.1× 402 2.5× 156 1.0× 151 1.2× 39 1.1k
Thilo Schlott Germany 18 390 0.9× 266 1.2× 97 0.6× 116 0.7× 132 1.0× 51 855
Christopher A. Lundquist United States 8 740 1.7× 346 1.6× 182 1.1× 116 0.7× 174 1.3× 9 1.3k
Yoshiro Kamachi Japan 15 388 0.9× 169 0.8× 112 0.7× 310 1.9× 309 2.4× 24 1.1k
Ivan Lončarević Germany 18 353 0.8× 79 0.4× 155 1.0× 67 0.4× 68 0.5× 41 902
Sophie Allart France 18 312 0.7× 195 0.9× 261 1.6× 51 0.3× 272 2.1× 31 1.0k
Tsuyoshi Tange Japan 12 413 0.9× 256 1.2× 118 0.7× 68 0.4× 367 2.8× 26 1.2k
G. Spira Israel 21 673 1.5× 208 0.9× 410 2.5× 161 1.0× 265 2.0× 49 1.5k
Ephraim Ansa-Addo United States 19 735 1.7× 196 0.9× 221 1.4× 246 1.5× 476 3.6× 29 1.3k

Countries citing papers authored by Andreas Klein

Since Specialization
Citations

This map shows the geographic impact of Andreas Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Klein more than expected).

Fields of papers citing papers by Andreas Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Klein. The network helps show where Andreas Klein may publish in the future.

Co-authorship network of co-authors of Andreas Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Klein. A scholar is included among the top collaborators of Andreas Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Klein. Andreas Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karthaus, Meinolf, Jorge Riera‐Knorrenschild, A. Kretzschmar, et al.. (2022). Efficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial. ESMO Open. 7(1). 100391–100391. 9 indexed citations
2.
Häckel, Sonja, Sebastian Stricker, Andreas Klein, et al.. (2018). Inositol-C2-PAF acts as a biological response modifier and antagonizes cancer-relevant processes in mammary carcinoma cells. Cellular Oncology. 41(5). 505–516. 2 indexed citations
3.
4.
Jenke, Andreas, Kai O. Hensel, Andreas Klein, et al.. (2014). Restitution of gene expression and histone acetylation signatures altered by hepatitis B virus through antiviral microRNA-like molecules in nontransformed murine hepatocytes. Clinical Epigenetics. 6(1). 26–26. 10 indexed citations
5.
Klein, Andreas, Lothar Lucka, Margarete Schön, et al.. (2013). Inositol-C2-PAF down-regulates components of the antigen presentation machinery in a 2D-model of epidermal inflammation. Biochemical Pharmacology. 87(3). 477–488. 9 indexed citations
6.
Gottschalk, Benjamin & Andreas Klein. (2013). Restoration of wild-type p53 in drug-resistant mouse breast cancer cells leads to differential gene expression, but is not sufficient to overcome the malignant phenotype. Molecular and Cellular Biochemistry. 379(1-2). 213–227. 4 indexed citations
7.
Klein, Andreas, Nan Li, Joshua M. Nicholson, et al.. (2010). Transgenic oncogenes induce oncogene-independent cancers with individual karyotypes and phenotypes. Cancer Genetics and Cytogenetics. 200(2). 79–99. 24 indexed citations
8.
Weidemann, Wenke, Christian Klukas, Andreas Klein, et al.. (2009). Lessons from GNE-deficient embryonic stem cells: sialic acid biosynthesis is involved in proliferation and gene expression. Glycobiology. 20(1). 107–117. 37 indexed citations
9.
Klein, Andreas, M. Graessmann, Iver Petersen, et al.. (2007). Comparison of gene expression data from human and mouse breast cancers: Identification of a conserved breast tumor gene set. International Journal of Cancer. 121(3). 683–688. 26 indexed citations
10.
11.
Klein, Andreas, Eva Guhl, Raphaël Zollinger, et al.. (2005). Gene expression profiling: cell cycle deregulation and aneuploidy do not cause breast cancer formation in WAP-SVT/t transgenic animals. Journal of Molecular Medicine. 83(5). 362–376. 26 indexed citations
12.
Torbenson, Michael, Davinder S. Grover, J. K. Boitnott, Andreas Klein, & Ernesto P. Molmenti. (2005). De Novo Hepatocellular Carcinoma in a Liver Allograft Associated with Recurrent Hepatitis B. Transplantation Proceedings. 37(5). 2205–2206. 12 indexed citations
13.
Kannangai, Rajesh, Ernesto P. Molmenti, Andreas Klein, et al.. (2004). Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection. Journal of Viral Hepatitis. 11(4). 297–301. 37 indexed citations
14.
Klein, Andreas, Eva Guhl, Yin‐Jeh Tzeng, et al.. (2003). HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53. Oncogene. 22(19). 2910–2919. 37 indexed citations
15.
Safadi, Rifaat, Reuven Or, Yaron Ilan, et al.. (2001). Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplantation. 27(2). 183–190. 64 indexed citations
16.
Pickartz, Tilman, Frauke Ringel, Marianne Wedde, et al.. (2001). Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab. Experimental Hematology. 29(12). 1410–1416. 22 indexed citations
17.
18.
Klein, Andreas, et al.. (1997). The TATA-less promoter of hepatitis B virus S gene contains a TBP binding site and an active initiator. Virus Research. 49(1). 1–7. 12 indexed citations
19.
Geißler, R. G., Rita Rossol, Oliver G. Ottmann, et al.. (1996). γδ-T Cell-Receptor-Positive Lymphocytes Inhibit Human Hematopoietic Progenitor Cell Growth in HIV Type 1-Infected Patients. AIDS Research and Human Retroviruses. 12(7). 577–584. 13 indexed citations
20.
Manny, Noga, et al.. (1995). A study of Israeli blood donors, asymptomatic carriers of hepatitis C virus, in relation to liver disease, cryoglobulinemia and transmission.. PubMed. 31(5). 277–9. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefanie Mandl Breakdown of academic impact, for papers by Francesca De Nicola Breakdown of academic impact, for papers by Thilo Schlott Breakdown of academic impact, for papers by Christopher A. Lundquist Breakdown of academic impact, for papers by Yoshiro Kamachi Breakdown of academic impact, for papers by Ivan Lončarević Breakdown of academic impact, for papers by Sophie Allart Breakdown of academic impact, for papers by Tsuyoshi Tange Breakdown of academic impact, for papers by G. Spira Breakdown of academic impact, for papers by Ephraim Ansa-Addo
Rankless by CCL
2026